Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis: Immunohistochemical and electron microscopic study

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 11, 2000, Pages 1642-1648

  Matsui, K ^a   Riemenschneider, W K ^a   Hilbert, S L ^a   Yu, Z X ^a   Takeda, K ^a   Travis, W D ^a   Moss, J ^a   Ferrans, V J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; CELL NUCLEUS ANTIGEN; LUNG SURFACTANT; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAMELLAR BODY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LYMPHANGIOLEIOMYOMATOSIS; MICROVILLUS; MORPHOLOGY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; APOLIPOPROTEINS A; FEMALE; HUMANS; HYPERPLASIA; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MATRIX METALLOPROTEINASE 1; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANSCRIPTION FACTORS;

EID: 0033732271     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pulmonary lymphangiomyomatosis: A review
2. Lymphangioleiomyomatosis: Clinical course in 32 patients
3. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis
4. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis
5. Histopathologic studies on lymphangioleiomyomatosis
6. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis (LAM)
7. Diffuse pulmonary lymphangiomatosis
8. Characterization of the melanosome-containing smooth muscle cells in lymphangioleiomyomatosis (LAM): Inverse correlation between markers of cell proliferation and expression of melanosomal antigens
9. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: Association of Bcl-2 expression with hormone receptor status
10. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)
11. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis
12. Pulmonary mechanics in lymphangioleiomyomatosis
13. Down regulation of estrogen (ER) and progesterone (PR) receptors in the abnormal smooth muscle celts in pulmonary lymphangioleiomyomatosis following therapy: An immunohistochemical study
14. Transbronchial biopsy in lymphangiomyomatosis of the lung: HMB45 for diagnosis
15. Pulmonary lymphangioleiomyomatosis: Diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high-resolution computed tomography findings
16. Pulmonary lymphangiomyomatosis and tuberous sclerosis: Comparison of radiographic and thin-section CT findings
17. Ultrastructure of the proliferating cells in pulmonary lymphangiomyomatosis
18. Lymphangioleiomyomatosis: New insights
19. Acute interstitial pneumonia: A clinicopathologic, ultrastructural, and cell kinetic study
20. Alveolar type II cells
21. Diffuse alveolar damage and acute interstitial pneumonitis: Histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV
22. Hyperplasia of type II pneumocytes in acute lung injury: Cytologic findings of sequential bronchoalveolar lavage
23. Molecular characterization of the melanocyte lineage-specific antigen gp100
24. Monoclonal antibodies against human pulmonary surfactant apoproteins: Specificity and application in immunoassay
25. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis
26. Regulation of surfactant protein gene transcription
27. Distribution and subcellular localization of surfactant-associated glycoproteins in human lung
28. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma
29. Respiratory epithelial-mesenchymal interface in patients with fibrotic lung diseases
30. Ultrastructural analysis of the pneumocyte-interstitium boundary line in the course of enzymatic lung injury
31. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification
32. Alveolar epithelial cells in experimental lung emphysema: Ultrastructural analysis of cells in situ in TEM
33. Animal models of emphysema
34. Scanning electron microscopic observations of emphysema in humans: A descriptive study
35. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice
36. Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors
37. Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats
38. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo
39. Epithelial cell-derived transforming growth factor-beta in bleomycin-induced pulmonary injury
40. Insulin-like growth factor-1 and type I insulin-like growth factor receptor in 85% O2-exposed rat lung